Investor Hep Investments Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Hep Investments Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2024-10-01 13D/A ZIVOW / ZIVO Bioscience, Inc. - Equity Warrant 530,989
2024-03-14 13D/A 488,785
2020-03-05 13D/A HEPI / 221,773,179
2019-02-27 13D/A ZIVO / ZIVO Bioscience, Inc. 265,929,111 311,651,754
2018-04-25 13D ZIVO / ZIVO Bioscience, Inc. 265,929,111 265,929,111
2018-04-24 13D ZIVO / ZIVO Bioscience, Inc. 210,566,723 265,929,111
2017-09-20 13D/A ZIVO / ZIVO Bioscience, Inc. 148,522,917 210,566,723
2017-04-21 13D/A ZIVO / ZIVO Bioscience, Inc. 90,487,116 148,522,917
2016-04-29 13D/A ZIVO / ZIVO Bioscience, Inc. 56,386,359 90,487,116
2015-05-01 13D ZIVO / ZIVO Bioscience, Inc. 56,386,359
2014-09-04 13G HEPI / 43,423,613